Literature DB >> 31439509

Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration.

Annamaria Bevivino1, Giovanni Bacci2, Pavel Drevinek3, Maria T Nelson4, Lucas Hoffman5, Alessio Mengoni2.   

Abstract

Despite over a decade of cystic fibrosis (CF) microbiome research, much remains to be learned about the overall composition, metabolic activities, and pathogenicity of the microbes in CF airways, limiting our understanding of the respiratory microbiome's relation to disease. Systems-level integration and modeling of host-microbiome interactions may allow us to better define the relationships between microbiological characteristics, disease status, and treatment response. In this way, modeling could pave the way for microbiome-based development of predictive models, individualized treatment plans, and novel therapeutic approaches, potentially serving as a paradigm for approaching other chronic infections. In this review, we describe the challenges facing this effort and propose research priorities for a systems biology approach to CF lung disease.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  cystic fibrosis; longitudinal studies; microbiome; microbiome-based therapy; predictive modeling; systems biology

Mesh:

Year:  2019        PMID: 31439509     DOI: 10.1016/j.molmed.2019.07.008

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  18 in total

1.  Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.

Authors:  Catherine R Armbruster; Tom Coenye; Lhousseine Touqui; Jennifer M Bomberger
Journal:  J Cyst Fibros       Date:  2019-11-02       Impact factor: 5.482

2.  Citizen-science based study of the oral microbiome in Cystic fibrosis and matched controls reveals major differences in diversity and abundance of bacterial and fungal species.

Authors:  Jesse R Willis; Ester Saus; Susana Iraola-Guzmán; Elena Cabello-Yeves; Ewa Ksiezopolska; Luca Cozzuto; Luis A Bejarano; Nuria Andreu-Somavilla; Miriam Alloza-Trabado; Andrea Blanco; Anna Puig-Sola; Elisabetta Broglio; Carlo Carolis; Julia Ponomarenko; Jochen Hecht; Toni Gabaldón
Journal:  J Oral Microbiol       Date:  2021-05-17       Impact factor: 5.474

Review 3.  Factoring in the Complexity of the Cystic Fibrosis Lung to Understand Aspergillus fumigatus and Pseudomonas aeruginosa Interactions.

Authors:  Emily Beswick; Jorge Amich; Sara Gago
Journal:  Pathogens       Date:  2020-08-06

4.  The Lung Microbiome of Three Young Brazilian Patients With Cystic Fibrosis Colonized by Fungi.

Authors:  Otávio Guilherme Gonçalves de Almeida; Carolina Paulino da Costa Capizzani; Ludmilla Tonani; Patrícia Helena Grizante Barião; Anderson Ferreira da Cunha; Elaine Cristina Pereira De Martinis; Lidia Alice Gomes Monteiro Marin Torres; Marcia Regina von Zeska Kress
Journal:  Front Cell Infect Microbiol       Date:  2020-11-11       Impact factor: 5.293

5.  Azithromycin and the microbiota of cystic fibrosis sputum.

Authors:  Nicole Acosta; Christina S Thornton; Michael G Surette; Ranjani Somayaji; Laura Rossi; Harvey R Rabin; Michael D Parkins
Journal:  BMC Microbiol       Date:  2021-03-30       Impact factor: 3.605

6.  Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients.

Authors:  Anne H Neerincx; Katrine Whiteson; Joann L Phan; Paul Brinkman; Mahmoud I Abdel-Aziz; Els J M Weersink; Josje Altenburg; Christof J Majoor; Anke H Maitland-van der Zee; Lieuwe D J Bos
Journal:  ERJ Open Res       Date:  2021-04-19

Review 7.  Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives.

Authors:  Giovanni Taccetti; Michela Francalanci; Giovanna Pizzamiglio; Barbara Messore; Vincenzo Carnovale; Giuseppe Cimino; Marco Cipolli
Journal:  Antibiotics (Basel)       Date:  2021-03-22

8.  Conceptual Exchanges for Understanding Free-Living and Host-Associated Microbiomes.

Authors:  Catherine A Pfister; Samuel H Light; Brendan Bohannan; Thomas Schmidt; Adam Martiny; Nicole A Hynson; Suzanne Devkota; Lawrence David; Katrine Whiteson
Journal:  mSystems       Date:  2022-01-11       Impact factor: 7.324

Review 9.  Metabolic Modeling to Interrogate Microbial Disease: A Tale for Experimentalists.

Authors:  Fabrice Jean-Pierre; Michael A Henson; George A O'Toole
Journal:  Front Mol Biosci       Date:  2021-02-18

Review 10.  Metaproteomics to Decipher CF Host-Microbiota Interactions: Overview, Challenges and Future Perspectives.

Authors:  Pauline Hardouin; Raphael Chiron; Hélène Marchandin; Jean Armengaud; Lucia Grenga
Journal:  Genes (Basel)       Date:  2021-06-09       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.